| Julius J Laguerre, MD | |
|
230 North Rd, Poughkeepsie, NY 12601-1328 | |
| (845) 486-2703 | |
| (845) 486-2865 |
| Full Name | Julius J Laguerre |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 54 Years |
| Location | 230 North Rd, Poughkeepsie, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306838172 | NPI | - | NPPES |
| 143342-1 | Other | NY | MD LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 143342-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Supports For Living Inc | 8729992730 | 30 |
News Archive
Researchers at The University of Texas have found that compared to Caucasian Americans, African Americans have impaired blood flow regulation in the brain that could contribute to a greater risk of cerebrovascular diseases such as stroke, transient ischaemic attack ("mini stroke"), subarachnoid haemorrhage or vascular dementia.
Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for the UK.
In human trials, the interim analysis of 275 participants showed REGEN-COV quickly reduced viral loads. Moreover, this reduction was much faster in people who did not have a high viral load when they started treatment.
Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
› Verified 8 days ago
| Entity Name | Access: Supports For Living Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528174976 PECOS PAC ID: 8729992730 Enrollment ID: O20031114000141 |
News Archive
Researchers at The University of Texas have found that compared to Caucasian Americans, African Americans have impaired blood flow regulation in the brain that could contribute to a greater risk of cerebrovascular diseases such as stroke, transient ischaemic attack ("mini stroke"), subarachnoid haemorrhage or vascular dementia.
Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for the UK.
In human trials, the interim analysis of 275 participants showed REGEN-COV quickly reduced viral loads. Moreover, this reduction was much faster in people who did not have a high viral load when they started treatment.
Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julius J Laguerre, MD 29 N Hamilton St, Poughkeepsie, NY 12601-2541 Ph: (845) 452-1110 | Julius J Laguerre, MD 230 North Rd, Poughkeepsie, NY 12601-1328 Ph: (845) 486-2703 |
News Archive
Researchers at The University of Texas have found that compared to Caucasian Americans, African Americans have impaired blood flow regulation in the brain that could contribute to a greater risk of cerebrovascular diseases such as stroke, transient ischaemic attack ("mini stroke"), subarachnoid haemorrhage or vascular dementia.
Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on Human Medicines (CHM), the government's independent expert scientific advisory body, the MHRA has approved Ronapreve as the first monoclonal antibody combination product indicated for use in the prevention and treatment of acute COVID-19 infection for the UK.
In human trials, the interim analysis of 275 participants showed REGEN-COV quickly reduced viral loads. Moreover, this reduction was much faster in people who did not have a high viral load when they started treatment.
Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
› Verified 8 days ago
Dr. Eldene Gwen Towey, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd # A, Poughkeepsie, NY 12601 Phone: 845-483-5000 | |
Sadaf R Ahsan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 845-483-8743 Fax: 845-485-3809 | |
Dr. Karanjit Singh Parihar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd # A, Poughkeepsie, NY 12601 Phone: 845-483-5000 | |
Gulnaz Kiyamova, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 914-909-9018 Fax: 914-909-9028 | |
Dr. Thomas D Steeves, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 21 Reade Pl Ste 1100, Poughkeepsie, NY 12601 Phone: 845-214-1922 | |
Khaled I Mohamed, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 845-431-8287 | |
Dr. Jihyuk Han, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 Manchester Road, Suite 203a, Poughkeepsie, NY 12603 Phone: 845-485-5000 Fax: 845-485-5002 |